Additionally, 17-beta hydroxysteroid dehydrogenase 13 (HSD17B13) was identified as having the protective role of NAFLD [49] and protecting against HCC development [50]. This evidence concerns the gene HSD17B13 and metabolic dysfunction-associated steatotic liver disease.